Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176884 | SCV000228642 | likely benign | not specified | 2016-07-26 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000864161 | SCV001004925 | benign | Nephronophthisis | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001099939 | SCV001256432 | uncertain significance | Nephronophthisis 4 | 2017-09-08 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001101945 | SCV001258589 | uncertain significance | Senior-Loken syndrome 4 | 2017-09-08 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Gene |
RCV001753581 | SCV001986060 | uncertain significance | not provided | 2020-07-02 | criteria provided, single submitter | clinical testing | Reported previously in trans with 2 other missense variants in NPHP4 in a patient with with a complex phenotype including skeletal and renal dysplasia, immunodeficiency, retinal degeneration and ovarian failure; however this proband was also noted have multiple other nonsynonomous gene variants either in the homozygous or compound heterozygous state and to have UPD2 (Carmichael et al., 2013); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23167750) |
Mayo Clinic Laboratories, |
RCV001753581 | SCV004227720 | uncertain significance | not provided | 2022-10-05 | criteria provided, single submitter | clinical testing | BS1 |
Prevention |
RCV003927634 | SCV004741179 | likely benign | NPHP4-related condition | 2019-09-17 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |